Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q9P6
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 118 | 122 | PF00656 | 0.457 |
CLV_NRD_NRD_1 | 215 | 217 | PF00675 | 0.491 |
CLV_NRD_NRD_1 | 225 | 227 | PF00675 | 0.523 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.434 |
CLV_PCSK_KEX2_1 | 217 | 219 | PF00082 | 0.497 |
CLV_PCSK_KEX2_1 | 225 | 227 | PF00082 | 0.523 |
CLV_PCSK_PC1ET2_1 | 132 | 134 | PF00082 | 0.434 |
CLV_PCSK_PC1ET2_1 | 217 | 219 | PF00082 | 0.497 |
CLV_PCSK_SKI1_1 | 129 | 133 | PF00082 | 0.509 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.433 |
DOC_CYCLIN_RxL_1 | 193 | 203 | PF00134 | 0.623 |
DOC_CYCLIN_yCln2_LP_2 | 123 | 126 | PF00134 | 0.466 |
DOC_PP2B_LxvP_1 | 123 | 126 | PF13499 | 0.471 |
DOC_PP2B_LxvP_1 | 198 | 201 | PF13499 | 0.659 |
DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.651 |
DOC_USP7_MATH_1 | 106 | 110 | PF00917 | 0.595 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.478 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.700 |
LIG_14-3-3_CanoR_1 | 37 | 44 | PF00244 | 0.481 |
LIG_14-3-3_CanoR_1 | 9 | 18 | PF00244 | 0.371 |
LIG_Actin_WH2_2 | 113 | 131 | PF00022 | 0.506 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.574 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.472 |
LIG_FHA_1 | 28 | 34 | PF00498 | 0.519 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.408 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.608 |
LIG_FHA_2 | 103 | 109 | PF00498 | 0.610 |
LIG_HCF-1_HBM_1 | 137 | 140 | PF13415 | 0.398 |
LIG_IRF3_LxIS_1 | 18 | 24 | PF10401 | 0.459 |
LIG_LIR_Apic_2 | 51 | 57 | PF02991 | 0.485 |
LIG_LIR_Apic_2 | 69 | 73 | PF02991 | 0.444 |
LIG_LIR_Gen_1 | 137 | 147 | PF02991 | 0.458 |
LIG_LIR_Nem_3 | 137 | 143 | PF02991 | 0.464 |
LIG_SH2_CRK | 54 | 58 | PF00017 | 0.460 |
LIG_SH2_CRK | 70 | 74 | PF00017 | 0.408 |
LIG_SH2_GRB2like | 54 | 57 | PF00017 | 0.450 |
LIG_SH2_NCK_1 | 140 | 144 | PF00017 | 0.446 |
LIG_SH2_NCK_1 | 54 | 58 | PF00017 | 0.460 |
LIG_SH2_NCK_1 | 70 | 74 | PF00017 | 0.408 |
LIG_SH2_STAP1 | 140 | 144 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 144 | 147 | PF00017 | 0.365 |
LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.422 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.390 |
LIG_SH3_3 | 161 | 167 | PF00018 | 0.460 |
LIG_SUMO_SIM_anti_2 | 19 | 24 | PF11976 | 0.433 |
LIG_SUMO_SIM_par_1 | 18 | 24 | PF11976 | 0.403 |
LIG_TRAF2_1 | 105 | 108 | PF00917 | 0.507 |
LIG_TRFH_1 | 70 | 74 | PF08558 | 0.524 |
MOD_CK1_1 | 92 | 98 | PF00069 | 0.700 |
MOD_CK2_1 | 102 | 108 | PF00069 | 0.627 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.509 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.694 |
MOD_GlcNHglycan | 222 | 225 | PF01048 | 0.612 |
MOD_GlcNHglycan | 227 | 230 | PF01048 | 0.657 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.357 |
MOD_GlcNHglycan | 231 | 234 | PF01048 | 0.630 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.613 |
MOD_GlcNHglycan | 81 | 84 | PF01048 | 0.645 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.713 |
MOD_GSK3_1 | 151 | 158 | PF00069 | 0.528 |
MOD_GSK3_1 | 225 | 232 | PF00069 | 0.693 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.443 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.567 |
MOD_N-GLC_1 | 89 | 94 | PF02516 | 0.592 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.403 |
MOD_NEK2_1 | 219 | 224 | PF00069 | 0.615 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.648 |
MOD_PIKK_1 | 151 | 157 | PF00454 | 0.438 |
MOD_PKA_1 | 225 | 231 | PF00069 | 0.643 |
MOD_PKA_2 | 155 | 161 | PF00069 | 0.557 |
MOD_PKA_2 | 219 | 225 | PF00069 | 0.637 |
MOD_PKA_2 | 8 | 14 | PF00069 | 0.568 |
MOD_PKB_1 | 216 | 224 | PF00069 | 0.553 |
MOD_Plk_4 | 16 | 22 | PF00069 | 0.379 |
TRG_DiLeu_BaLyEn_6 | 1 | 6 | PF01217 | 0.522 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.514 |
TRG_ENDOCYTIC_2 | 144 | 147 | PF00928 | 0.357 |
TRG_ER_diArg_1 | 175 | 178 | PF00400 | 0.604 |
TRG_ER_diArg_1 | 215 | 218 | PF00400 | 0.493 |
TRG_NLS_MonoExtC_3 | 215 | 220 | PF00514 | 0.494 |
TRG_NLS_MonoExtN_4 | 214 | 221 | PF00514 | 0.555 |
TRG_Pf-PMV_PEXEL_1 | 37 | 41 | PF00026 | 0.434 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I303 | Leptomonas seymouri | 64% | 100% |
A0A1X0NZI8 | Trypanosomatidae | 43% | 92% |
A0A3R7P4N9 | Trypanosoma rangeli | 44% | 100% |
A0A3S7WZA1 | Leishmania donovani | 94% | 100% |
A4HE95 | Leishmania braziliensis | 82% | 100% |
A4I1P1 | Leishmania infantum | 94% | 100% |
C9ZK90 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
E9AXS5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |